pharmaphorum February 6, 2024
Nicole Raleigh

EU Clinical Trials Regulation (EU CTR) has been a hot topic for a little while now. An initiative launched by the European Commission, EMA, and national regulators within the EU in 2022 in order to change the way clinical trials are designed and run, so as to position Europe as an area of clinical trial excellence internationally, via a harmonised strategy between member states – the deadline for sponsors to transition ongoing trials to EU CTR comes into effect in January 2025.

So it was that for the latest episode of the pharmaphorum podcast web editor Nicole Raleigh sat down with Chris Bamford, director of clinical trial regulatory management at IQVIA, and Shirley Rutter, associate director and strategic quality lead...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Clinical Trials, Conferences / Podcast, Govt Agencies, Regulations, Trends
Related Articles:
Future Trends for Clinical Trials in 2025 and Beyond
The Future of Clinical Trials: Four Key Trends to Watch in 2025
Small cell lung cancer: Navigating the global clinical trial landscape
Generative AI has ‘potential to revolutionise clinical development’
Treating Covid burnout with ’shrooms

Share This Article